Bristol-Myers Squibb Company DSO Ratio 2011-2025 | BMY

Annual DSO Ratio Bristol-Myers Squibb Company

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
81.9	84.4	76.1	70.3	69.5	107	96.5	111	104	94.8	77.9	74.8	63.9	64.3

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
111	63.9	84

Quarterly DSO Ratio Bristol-Myers Squibb Company

2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
82.6	88.9	86.1	81.8	79.8	84.9	82	80.2	-	39.1	32.7	70	-	71.7	68.9	70.7	70.1	73.6	76.6	68.5	88.3	117	112	104	89.5	95.6	95.4	108	106	109	112	110	96.5	103	104	102	91.5	96.4	94.2	86.8	72.7	78.9	79.5	80.8	69	75.4	75.7	76.7	67.1	75.3	63.3	59.3	62.6	63.9	62.9	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
117	32.7	82.8

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Amphastar Pharmaceuticals AMPH	62.6	$ 25.27	-2.43 %	$ 1.22 B	USA
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Arbutus Biopharma Corporation ABUS	31.5	$ 4.75	1.61 %	$ 788 M	Canada
Aclaris Therapeutics ACRS	6.01	$ 3.26	-3.12 %	$ 252 M	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	25	-	-15.15 %	$ 60.3 M	Britain
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
Kamada Ltd. KMDA	103	$ 7.03	0.14 %	$ 260 M	Israel
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Ascendis Pharma A/S ASND	132	$ 220.27	4.81 %	$ 5 B	Danmark
Albireo Pharma ALBO	14.7	-	-0.23 %	$ 916 M	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Can-Fite BioPharma Ltd. CANF	28.1	$ 0.28	-2.28 %	$ 609 M	Israel
Alterity Therapeutics Limited ATHE	16.2 K	$ 3.3	-3.51 %	$ 7.94 B	Australia
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
Anika Therapeutics ANIK	77.3	$ 9.57	0.84 %	$ 140 M	USA
Brickell Biotech BBI	254	-	-5.38 %	$ 6.06 M	USA
BeiGene, Ltd. BGNE	49.5	-	0.49 %	$ 251 B	Cayman-islands
Bellicum Pharmaceuticals BLCM	6.09	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	103	-	-7.31 %	$ 87 M	USA
Benitec Biopharma BNTC	141	$ 12.05	-7.06 %	$ 496 M	USA
Aytu BioScience AYTU	150	$ 2.34	2.59 %	$ 14.7 M	USA
Nymox Pharmaceutical Corporation NYMX	12.5	-	-19.68 %	$ 18.4 M	Canada
Arena Pharmaceuticals ARNA	946	-	-6.81 %	$ 3.04 B	USA
Aptorum Group Limited APM	20.6	$ 1.29	-3.01 %	$ 7.03 M	China
Baudax Bio BXRX	126	-	0.59 %	$ 63 K	USA
Catalyst Biosciences CBIO	3.24	$ 14.01	-8.49 %	$ 922 M	USA
ChromaDex Corporation CDXC	13.2	-	-0.88 %	$ 598 M	USA
Axon Enterprise AXON	134	$ 566.18	-2.56 %	$ 42.9 B	USA
Cerus Corporation CERS	59.2	$ 2.16	0.47 %	$ 399 M	USA
Checkpoint Therapeutics CKPT	6.83	-	-	$ 169 M	USA
Caladrius Biosciences CLBS	164	-	-16.75 %	$ 25.8 M	USA
Clovis Oncology CLVS	65.5	-	-7.23 %	$ 13 M	USA
Biogen BIIB	57.9	$ 174.42	1.11 %	$ 25.4 B	USA
Celldex Therapeutics CLDX	86.5	$ 27.36	-2.09 %	$ 1.76 M	USA
Deciphera Pharmaceuticals DCPH	60.8	-	-	$ 2.18 B	USA
Biohaven Pharmaceutical Holding Company Ltd. BHVN	169	$ 11.54	0.87 %	$ 746 M	USA